1. Home
  2. VMI vs HALO Comparison

VMI vs HALO Comparison

Compare VMI & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VMI
  • HALO
  • Stock Information
  • Founded
  • VMI 1946
  • HALO 1998
  • Country
  • VMI United States
  • HALO United States
  • Employees
  • VMI N/A
  • HALO N/A
  • Industry
  • VMI Metal Fabrications
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VMI Industrials
  • HALO Health Care
  • Exchange
  • VMI Nasdaq
  • HALO Nasdaq
  • Market Cap
  • VMI 6.5B
  • HALO 7.4B
  • IPO Year
  • VMI N/A
  • HALO N/A
  • Fundamental
  • Price
  • VMI $358.61
  • HALO $59.02
  • Analyst Decision
  • VMI Buy
  • HALO Buy
  • Analyst Count
  • VMI 3
  • HALO 8
  • Target Price
  • VMI $391.00
  • HALO $65.63
  • AVG Volume (30 Days)
  • VMI 183.1K
  • HALO 1.4M
  • Earning Date
  • VMI 07-22-2025
  • HALO 08-05-2025
  • Dividend Yield
  • VMI 0.76%
  • HALO N/A
  • EPS Growth
  • VMI 33.33
  • HALO 55.40
  • EPS
  • VMI 10.81
  • HALO 3.76
  • Revenue
  • VMI $4,077,331,000.00
  • HALO $1,084,306,000.00
  • Revenue This Year
  • VMI $1.67
  • HALO $25.38
  • Revenue Next Year
  • VMI $5.09
  • HALO $20.19
  • P/E Ratio
  • VMI $33.18
  • HALO $15.70
  • Revenue Growth
  • VMI N/A
  • HALO 25.64
  • 52 Week Low
  • VMI $250.07
  • HALO $42.01
  • 52 Week High
  • VMI $379.22
  • HALO $70.51
  • Technical
  • Relative Strength Index (RSI)
  • VMI 63.12
  • HALO 59.06
  • Support Level
  • VMI $352.60
  • HALO $57.68
  • Resistance Level
  • VMI $367.25
  • HALO $61.75
  • Average True Range (ATR)
  • VMI 7.54
  • HALO 1.37
  • MACD
  • VMI 1.29
  • HALO 0.18
  • Stochastic Oscillator
  • VMI 78.93
  • HALO 55.32

About VMI Valmont Industries Inc.

Valmont Industries Inc, along with its subsidiaries, operates as a manufacturer of products and services for infrastructure and agriculture markets. Its reportable segments are Infrastructure and Agriculture. The company generates maximum revenue from the Infrastructure segment, which includes the manufacturing and distribution of products and solutions to serve the infrastructure markets of utility, solar, lighting and transportation, and telecommunications, along with coatings services to protect metal products. The Agriculture segment provides irrigation equipment components, including aftermarket parts and tubular products, and technology solutions for precision agriculture. Geographically, it derives key revenue from the United States, followed by Australia, Brazil, and other regions.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: